TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Establishment Labs Is Maintained at Neutral by Citigroup
Establishment Labs Hldgs Analyst Ratings
Citi Maintains Establishment Labs(ESTA.US) With Hold Rating, Raises Target Price to $50
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Alkermes (ALKS) and Axsome Therapeutics (AXSM)
Jefferies Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $67
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $62
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Buy Rating Affirmed: Establishment Labs' Motiva Implant Poised to Disrupt the US Breast Implant Market
Establishment Labs Hldgs Analyst Ratings
Citi Maintains Establishment Labs(ESTA.US) With Hold Rating, Cuts Target Price to $45
Establishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short Interest
Establishment Labs Price Target Maintained With a $68.00/Share by Stephens & Co.
Establishment Labs Hldgs Analyst Ratings
JP Morgan Maintains Overweight on Establishment Labs Hldgs, Lowers Price Target to $50
Establishment Labs Holdings Poised for U.S. Market Entry: A Buy Rating Analysis
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Citigroup Maintains Neutral on Establishment Labs Hldgs, Lowers Price Target to $50